Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Enhancing immunotherapy with cytokines

Sebastian Kobold, MD, PhD, Ludwig-Maximilians-Universität München, Munich, Germany, discusses the challenges with the use of cytokines for cancer treatment. Besides the approval of IL-2 for advanced metastatic melanoma, there has been little progress within this particular field. Antibodies may be used to neutralize the effect of cytokines and cytokines may be used to enhance immune cell function. As such, combining cytokines with immunotherapy has seen success in early clinical studies. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.